Michael Näbauer
YOU?
Author Swipe
View article: Thromboembolic risk of electrical cardioversion in patients with cardiogenic shock
Thromboembolic risk of electrical cardioversion in patients with cardiogenic shock Open
View article: Choosing Between Tricuspid Repair or Replacement: Decision Algorithms
Choosing Between Tricuspid Repair or Replacement: Decision Algorithms Open
Transcatheter tricuspid valve (TV) interventions have transformed the treatment of TV disease. Among available therapies, transcatheter tricuspid edge-to-edge repair has shown favorable safety, symptom relief, quality-of-life improvement, …
View article: Hypoattenuated Leaflet Thickening and Reduced Leaflet Motion After Transcatheter Tricuspid Valve Replacement
Hypoattenuated Leaflet Thickening and Reduced Leaflet Motion After Transcatheter Tricuspid Valve Replacement Open
HALT and RLMCT are common after TTVR and are associated with elevated gradients, and reduced symptomatic improvement. Transthoracic echocardiography is insensitive for detecting HALT and RLM, and routine CT may aid early diagnos…
View article: Transient thrombocytopenia following transcatheter tricuspid valve interventions
Transient thrombocytopenia following transcatheter tricuspid valve interventions Open
View article: Impact of dual atrioventricular valve disease on outcomes in patients undergoing transcatheter aortic valve replacement
Impact of dual atrioventricular valve disease on outcomes in patients undergoing transcatheter aortic valve replacement Open
Aims Current guidelines provide no recommendations for the management of patients with dual atrioventricular valve regurgitation (DAVR) undergoing transcatheter aortic valve replacement (TAVR), and existing data on its clinical impact rema…
View article: Correction: Management of atrial fibrillation: two decades of progress — a scientific statement from the European Cardiac Arrhythmia Society
Correction: Management of atrial fibrillation: two decades of progress — a scientific statement from the European Cardiac Arrhythmia Society Open
View article: Transcatheter Tricuspid Valve Edge-to-Edge Repair in Cardiac Wild-Type Transthyretin Amyloidosis
Transcatheter Tricuspid Valve Edge-to-Edge Repair in Cardiac Wild-Type Transthyretin Amyloidosis Open
View article: Tricuspid regurgitation risk scores in patients undergoing tricuspid valve transcatheter edge‐to‐edge repair
Tricuspid regurgitation risk scores in patients undergoing tricuspid valve transcatheter edge‐to‐edge repair Open
View article: Beyond 2-Dimensional Echocardiography: A Novel Multiparametric Assessment of Right Ventricular Dysfunction in Transcatheter Tricuspid Valve Repair
Beyond 2-Dimensional Echocardiography: A Novel Multiparametric Assessment of Right Ventricular Dysfunction in Transcatheter Tricuspid Valve Repair Open
Data is based on the EveryValve Registry (ethical code number: 19-840). No further clinical Trial registration.
View article: Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry Open
Background Heart failure (HF) often occurs in patients with atrial fibrillation (AF), with a major impact on prognosis. Few data are available on the effect of integrated treatment strategies to improve prognosis in patients with AF. We ai…
View article: Biphasic Right Ventricular Reverse Remodeling Following Tricuspid Valve Transcatheter Edge-to-Edge Repair
Biphasic Right Ventricular Reverse Remodeling Following Tricuspid Valve Transcatheter Edge-to-Edge Repair Open
RVRR following T-TEER occurs in 2 stages and involves early RV unloading (reduction in RVEDV3D) and later structural RVRR (reduction in RVESV3D) with an improvement in RVEF.
View article: Relevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right‐sided heart failure
Relevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right‐sided heart failure Open
Aims Right ventricular reverse remodelling (RVRR) is linked to improved survival in patients with severe tricuspid regurgitation (TR) and right‐sided heart failure who underwent interventional treatment. However, the role of residual TR on…
View article: Burden of Heart Failure in Patients With Tricuspid Regurgitation and Effect of Transcatheter Repair on Different Subdimensions of Quality of Life
Burden of Heart Failure in Patients With Tricuspid Regurgitation and Effect of Transcatheter Repair on Different Subdimensions of Quality of Life Open
Background Right‐sided heart failure (HF) due to severe tricuspid regurgitation (TR) is associated with reduced quality of life (QoL). Here, we analyzed the impact of TR on specific QoL dimensions and the effect of transcatheter tricuspid …
View article: 4-Year Follow-Up After Transcatheter Tricuspid Valve Replacement Using the EVOQUE System
4-Year Follow-Up After Transcatheter Tricuspid Valve Replacement Using the EVOQUE System Open
Transcatheter tricuspid valve replacement (TTVR) is an increasingly used treatment technique for patients with severe tricuspid regurgitation (TR). Currently, available data from international registries and randomized controlled trials pr…
View article: Plasma proteome association with coronary heart disease and carotid intima media thickness: results from the KORA F4 study
Plasma proteome association with coronary heart disease and carotid intima media thickness: results from the KORA F4 study Open
View article: Mitral Valve Transcatheter Edge-to-Edge Repair
Mitral Valve Transcatheter Edge-to-Edge Repair Open
One-year outcomes of this large cohort from the MiCLASP study demonstrate continued safety and effectiveness of M-TEER with the PASCAL system in a post-market setting. Results demonstrate high survival and freedom from heart failure hospit…
View article: Ten Future Challenges in the Field of Transcatheter Mitral Valve Edge-to-Edge Repair
Ten Future Challenges in the Field of Transcatheter Mitral Valve Edge-to-Edge Repair Open
Mitral valve transcatheter edge-to-edge repair (M-TEER) and replacement (TMVR) have evolved as guideline-recommended treatment approaches for mitral regurgitation (MR). Even though they are supported by a growing body of evidence from eith…
View article: Successful Transcatheter Closure of Iatrogenic Mitral Regurgitation After Aortic Valve Surgery
Successful Transcatheter Closure of Iatrogenic Mitral Regurgitation After Aortic Valve Surgery Open
We present 2 cases of significant mitral regurgitation secondary to pericardial patch avulsion from the anterior mitral valve leaflet after aortic valve replacement with aortic annulus enlargement. Both cases were successfully managed by t…
View article: Simplified ELASTA-CLIP Before Transapical Mitral Valve Replacement
Simplified ELASTA-CLIP Before Transapical Mitral Valve Replacement Open
View article: Plasma Proteome Association with Coronary Heart Disease and Carotid Intima Media Thickness: results from the KORA F4 study
Plasma Proteome Association with Coronary Heart Disease and Carotid Intima Media Thickness: results from the KORA F4 study Open
Background and aims: Atherosclerosis is the main cause of stroke and coronary heart disease (CHD), both leading mortality causes worldwide. Proteomics, as a high-throughput method, could provide helpful insights into the pathological mecha…
View article: Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial
Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial Open
BACKGROUND: Tricuspid regurgitation (TR) is a common and progressive valve disease with significant mortality and hospitalization burden. Tricuspid transcatheter edge-to-edge repair provides a treatment option for high-risk patients with p…
View article: Impact of on-pump and off-pump coronary artery bypass grafting on 10-year mortality versus percutaneous coronary intervention
Impact of on-pump and off-pump coronary artery bypass grafting on 10-year mortality versus percutaneous coronary intervention Open
OBJECTIVES The very long-term mortality of off-pump and on-pump coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI) in a randomized complex coronary artery disease population is unknown. This study aims t…
View article: Cardio-hepatic syndrome in patients undergoing transcatheter aortic valve replacement
Cardio-hepatic syndrome in patients undergoing transcatheter aortic valve replacement Open
View article: Cardio‐hepatic syndrome in patients undergoing mitral valve transcatheter edge‐to‐edge repair
Cardio‐hepatic syndrome in patients undergoing mitral valve transcatheter edge‐to‐edge repair Open
Aims The impact of the cardio‐hepatic syndrome (CHS) on outcomes in patients undergoing mitral valve transcatheter edge‐to‐edge repair (M‐TEER) for relevant mitral regurgitation (MR) is unknown. The objectives of this study were three‐fold…
View article: Indocyanine green clearance predicts outcome in patients undergoing transcatheter valve intervention for severe atrio-ventricular valve regurgitation
Indocyanine green clearance predicts outcome in patients undergoing transcatheter valve intervention for severe atrio-ventricular valve regurgitation Open
OBJECTIVES Severe mitral regurgitation (MR) and tricuspid regurgitation (TR) aggravate haemodynamic stress leading to congestive heart failure with impaired hepatic function, also known as cardiohepatic syndrome (CHS). Current perioperativ…
View article: Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients Open
Background: Paroxysmal atrial fibrillation (AF) may often progress towards more sustained forms of the arrhythmia, but further research is needed on the factors associated with this clinical course. Methods: We analyzed patients enrolled i…
View article: Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry
Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry Open
Background Risk stratification in patients with atrial fibrillation (AF) is important to facilitate guideline-directed therapies. The Calculator of Absolute Stroke Risk (CARS) scheme enables an individualized estimation of 1-year absolute …
View article: Heterotopic Transcatheter Tricuspid Valve Replacement in a Patient With Carcinoid Heart Disease
Heterotopic Transcatheter Tricuspid Valve Replacement in a Patient With Carcinoid Heart Disease Open
Neuroendocrine tumors can lead to carcinoid heart disease with subsequent development of severe tricuspid regurgitation due to thickening and restriction of the tricuspid leaflets. We present a patient who underwent successful heterotopic …
View article: Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30‐day results
Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30‐day results Open
Background Severe tricuspid regurgitation (TR) is independently associated with increased morbidity and mortality. Percutaneous transcatheter approaches may offer an alternative for patients not amenable to surgery. Methods TriCLASP is a p…
View article: Right ventricular function in transcatheter mitral and tricuspid valve edge-to-edge repair
Right ventricular function in transcatheter mitral and tricuspid valve edge-to-edge repair Open
Since transcatheter edge-to-edge repair (TEER) has become a valuable therapy in the treatment of both, mitral (MR) and tricuspid regurgitation (TR), the question of optimized patient selection has gained growing importance. After years of …